Sean Wieland
Stock Analyst at Piper Sandler
(1.92)
# 2,875
Out of 4,789 analysts
30
Total ratings
42.86%
Success rate
1.68%
Average return
Main Sectors:
Stocks Rated by Sean Wieland
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Maintains: Overweight | $25 → $40 | $22.45 | +78.17% | 2 | Feb 28, 2025 | |
| OMCL Omnicell | Upgrades: Overweight | $70 → $39 | $34.96 | +11.56% | 11 | Nov 3, 2023 | |
| AMWL American Well | Maintains: Overweight | $100 → $120 | $7.88 | +1,422.84% | 2 | Jun 23, 2022 | |
| HIMS Hims & Hers Health | Maintains: Overweight | $8 → $6 | $29.55 | -79.70% | 3 | May 26, 2022 | |
| DOCS Doximity | Maintains: Overweight | $81 → $44 | $58.03 | -24.18% | 2 | May 19, 2022 | |
| IQV IQVIA Holdings | Maintains: Neutral | $261 → $231 | $176.30 | +31.03% | 4 | Feb 18, 2022 | |
| TDOC Teladoc Health | Maintains: Overweight | $305 → $291 | $7.96 | +3,555.78% | 5 | Feb 25, 2021 | |
| ACCD Accolade | Initiates: Overweight | $45 | $6.98 | +544.70% | 1 | Jul 27, 2020 |
Privia Health Group
Feb 28, 2025
Maintains: Overweight
Price Target: $25 → $40
Current: $22.45
Upside: +78.17%
Omnicell
Nov 3, 2023
Upgrades: Overweight
Price Target: $70 → $39
Current: $34.96
Upside: +11.56%
American Well
Jun 23, 2022
Maintains: Overweight
Price Target: $100 → $120
Current: $7.88
Upside: +1,422.84%
Hims & Hers Health
May 26, 2022
Maintains: Overweight
Price Target: $8 → $6
Current: $29.55
Upside: -79.70%
Doximity
May 19, 2022
Maintains: Overweight
Price Target: $81 → $44
Current: $58.03
Upside: -24.18%
IQVIA Holdings
Feb 18, 2022
Maintains: Neutral
Price Target: $261 → $231
Current: $176.30
Upside: +31.03%
Teladoc Health
Feb 25, 2021
Maintains: Overweight
Price Target: $305 → $291
Current: $7.96
Upside: +3,555.78%
Accolade
Jul 27, 2020
Initiates: Overweight
Price Target: $45
Current: $6.98
Upside: +544.70%